We are live on ! Find out more
TC

Trium Capital Portfolio holdings

AUM $163M Turnover 55%
1-Year Est. Return 45.8%
This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.8%
3 Year Est. Return
+188.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$20.6M
Cap. Flow
+$19M
Cap. Flow %
11.69%
Top 10 Hldgs %
79.52%
Holding
80
New
17
Increased
25
Reduced
11
Closed
27
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
ESPR icon
Esperion Therapeutics
ESPR
+$31.2M
2
T icon
AT&T
T
+$26.6M
3
ALMS icon
Alumis Inc
ALMS
+$4.63M
4
ELME icon
Elme Communities
ELME
+$4.37M
5
NEE icon
NextEra Energy
NEE
+$1.91M

Top Sells

Rank Stock Value
1
STKL
SunOpta
STKL
+$9.32M
2
HOLX icon
Hologic
HOLX
+$8.51M
3
OS
OneStream Inc
OS
+$6.55M
4
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$6.15M
5
SPNS icon
Sapiens International
SPNS
+$5.32M

Sector Composition

Rank Sector Weight
1 Communication Services 36.07%
2 Healthcare 29.44%
3 Industrials 14.19%
4 Technology 6.43%
5 Real Estate 3.8%

No holdings matched the selected filter criteria.

1 2 3 4

Similar funds

VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $163M AUM
ACM
Arrington Capital Management Miami, Florida $163M AUM
KFS
Krane Financial Solutions Calabasas, California $162M AUM
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $162M AUM
CCM
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
CFG
Cornerstone Financial Group Omaha, Nebraska $162M AUM 14.64% 1-Year Est. Return

Trium Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Trium Capital held 80 positions worth $163M, up 14% from $142M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Trium Capital deployed $19M of net new capital in Q2 2026, opening 17 new positions and adding to 25 existing holdings. Its largest new stake was Esperion Therapeutics: 11,158,150 shares worth $35.3M.

By sector, the portfolio is most concentrated in Communication Services at 36% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Sapiens International, an estimated $5.32M trimmed.

  • Trium Capital's largest Q2 2026 buy was Esperion Therapeutics: 11,158,150 shares worth $35.3M.
  • Trium Capital added most to AT&T in Q2 2026, an estimated $26.6M increase.
  • Trium Capital's biggest Q2 2026 reduction was Sapiens International, cutting an estimated $5.32M.
  • Trium Capital fully exited SunOpta in Q2 2026, selling an estimated $9.32M.
  • Trium Capital's ten largest holdings make up 80% of its $163M portfolio in Q2 2026.
  • Trium Capital opened 17 new positions and closed 27 in Q2 2026.
  • Trium Capital's portfolio value rose 14% quarter-over-quarter to $163M.

Based on Trium Capital's 13F filing for Q2 2026, filed 16 Jul 2026.